These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 17227809

  • 1. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept.
    Fatemi HM, Bourgain C, Donoso P, Blockeel C, Papanikolaou EG, Popovic-Todorovic B, Devroey P.
    Hum Reprod; 2007 May; 22(5):1260-3. PubMed ID: 17227809
    [Abstract] [Full Text] [Related]

  • 2. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG, Bourgain C, Kolibianakis E, Tournaye H, Devroey P.
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [Abstract] [Full Text] [Related]

  • 3. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study.
    Pirard C, Donnez J, Loumaye E.
    Hum Reprod; 2006 Jul; 21(7):1894-900. PubMed ID: 16556673
    [Abstract] [Full Text] [Related]

  • 4. Disturbances of the endometrium in the luteal phase of cycles stimulated for in vitro fertilization and of normal cycles treated with vaginal progesterone.
    Kresanov I, Nikkanen V, Klemi P.
    Ann Chir Gynaecol Suppl; 1994 Jul; 208():33-9. PubMed ID: 8092768
    [Abstract] [Full Text] [Related]

  • 5. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins.
    de Ziegler D, Bergeron C, Cornel C, Medalie DA, Massai MR, Milgrom E, Frydman R, Bouchard P.
    J Clin Endocrinol Metab; 1992 Feb; 74(2):322-31. PubMed ID: 1730810
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of micronised vaginal progesterone versus oral dydrogestrone in the treatment of irregular dysfunctional uterine bleeding: a pilot randomised controlled trial.
    Karakus S, Kiran G, Ciralik H.
    Aust N Z J Obstet Gynaecol; 2009 Dec; 49(6):685-8. PubMed ID: 20070724
    [Abstract] [Full Text] [Related]

  • 7. Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study.
    Ganesh A, Chakravorty N, Mukherjee R, Goswami S, Chaudhury K, Chakravarty B.
    Fertil Steril; 2011 May; 95(6):1961-5. PubMed ID: 21333984
    [Abstract] [Full Text] [Related]

  • 8. Progesterone administration in patients with absent ovaries.
    Devroey P, Palermo G, Bourgain C, Van Waesberghe L, Smitz J, Van Steirteghem AC.
    Int J Fertil; 1989 May; 34(3):188-93. PubMed ID: 2567713
    [Abstract] [Full Text] [Related]

  • 9. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC, Osório Wender MC, Sisson de Castro JA, dos Reis FM, Ruschel S, Magalhães JA, Spritzer PM.
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [Abstract] [Full Text] [Related]

  • 10. Effect of Oral versus Vaginal Administration of Estradiol and Dydrogesterone on the Proliferative and Secretory Transformation of Endometrium in Patients with Premature Ovarian Failure and Preparing for Assisted Reproductive Technology.
    Feng W, Nie L, Wang X, Yang F, Pan P, Deng X.
    Drug Des Devel Ther; 2021 Aug; 15():1521-1529. PubMed ID: 33883876
    [Abstract] [Full Text] [Related]

  • 11. Pilot study evaluating a progesterone vaginal ring for luteal-phase replacement in donor oocyte recipients.
    Stadtmauer L, Harrison DD, Boyd J, Bocca S, Oehninger S.
    Fertil Steril; 2009 Nov; 92(5):1600-5. PubMed ID: 18990373
    [Abstract] [Full Text] [Related]

  • 12. Changes in the ovarian dynamics and endocrine profiles in goats treated with a progesterone antagonist during the early luteal phase of the estrous cycle.
    Suganuma C, Kuroiwa T, Tanaka T, Kamomae H.
    Anim Reprod Sci; 2007 Oct; 101(3-4):285-94. PubMed ID: 17027203
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S, Chattopadhyay R, Goswami S, Chaudhury K, Chakravarty B, Ganesh A.
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [Abstract] [Full Text] [Related]

  • 20. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE, Hughes CL, Burger HG, Robertson DM, Fraser IS.
    Menopause; 2009 Jul; 16(1):50-9. PubMed ID: 18978637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.